Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvants…) as tools for cancer vaccines

This publication has 52 references indexed in Scilit:

• Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum?
  Trends in Cell Biology, 1998
• Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs)
  Vaccine, 1996
• Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens
  Vaccine, 1995
• Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides
  Immunological Reviews, 1995
• Induction of protective cytotoxic T cells with viral proteins
  European Journal of Immunology, 1994
• Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2
  JNCI Journal of the National Cancer Institute, 1994
• Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
  Journal of Clinical Investigation, 1994
• Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited
  Immunology Today, 1993
• Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.
  The Journal of Experimental Medicine, 1992
• Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells
  European Journal of Immunology, 1991